home / stock / ppcb / ppcb quote
Last: | $0.0015 |
---|---|
Change Percent: | 2.5% |
Open: | $0.00117 |
Close: | $0.0015 |
High: | $0.0015 |
Low: | $0.0011 |
Volume: | 4,321,125 |
Last Trade Date Time: | 05/08/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0015 | $0.00117 | $0.0015 | $0.0015 | $0.0011 | 4,321,125 | 05-08-2024 |
$0.0012 | $0.0011 | $0.0012 | $0.0013 | $0.0009 | 4,381,055 | 05-07-2024 |
$0.00098 | $0.0008 | $0.00098 | $0.0011 | $0.00075 | 5,800,592 | 05-06-2024 |
$0.0008 | $0.0008 | $0.0008 | $0.0008 | $0.0007 | 14,677,161 | 05-03-2024 |
$0.0008 | $0.0008 | $0.0008 | $0.0009 | $0.0007 | 13,194,740 | 05-02-2024 |
$0.0008 | $0.001 | $0.0008 | $0.001 | $0.0008 | 1,190,555 | 05-01-2024 |
$0.001 | $0.0008 | $0.001 | $0.001 | $0.0008 | 3,418,970 | 04-30-2024 |
$0.0009 | $0.001 | $0.0009 | $0.0011 | $0.0008 | 14,087,746 | 04-29-2024 |
$0.001 | $0.0011 | $0.001 | $0.0011 | $0.00095 | 3,347,792 | 04-26-2024 |
$0.0011 | $0.0011 | $0.0011 | $0.0011 | $0.001 | 1,676,690 | 04-25-2024 |
$0.00105 | $0.0011 | $0.00105 | $0.0011 | $0.001 | 1,446,200 | 04-24-2024 |
$0.0012 | $0.00115 | $0.0012 | $0.0012 | $0.001 | 1,610,545 | 04-23-2024 |
$0.0011 | $0.0011 | $0.0011 | $0.0015 | $0.001 | 12,454,791 | 04-22-2024 |
$0.0011 | $0.0011 | $0.0011 | $0.0013 | $0.001 | 5,550,947 | 04-19-2024 |
$0.001 | $0.0014 | $0.001 | $0.0014 | $0.001 | 11,368,010 | 04-18-2024 |
$0.0014 | $0.00144 | $0.0014 | $0.0015 | $0.0013 | 4,444,396 | 04-17-2024 |
$0.0013 | $0.0014 | $0.0013 | $0.0016 | $0.00128 | 6,326,497 | 04-16-2024 |
$0.0014 | $0.0017 | $0.0014 | $0.0017 | $0.0011 | 13,830,299 | 04-15-2024 |
$0.0017 | $0.0017 | $0.0017 | $0.0018 | $0.0015 | 1,555,100 | 04-12-2024 |
$0.0017 | $0.002 | $0.0017 | $0.002 | $0.0015 | 1,828,722 | 04-11-2024 |
News, Short Squeeze, Breakout and More Instantly...
Propanc Biopharma Inc Company Name:
PPCB Stock Symbol:
OTCMKTS Market:
Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that a certificate of grant for the Company’s &...
Show with Joel Block, “Your Advantage Play®, In Search of the Ultimate Competitive Advantage” Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for ...
Propanc Biopharma Inc (PPCB) is expected to report for Q2 2024 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 Arch Resources Inc. Class A (ARCH) is expected to report $6.9 for Q4 2023 Bloom Energy Corporation Class A (BE) is expected to report $-0.0...